BOOKS BY CATEGORY
Your Account
Working Group Report on Antibiotic Delinkage
This book is currently unavailable – please contact us for further information.
Price
Quantity
€17.02
(To see other currencies, click on price)
Paperback / softback
Add to basket  

MORE ABOUT THIS BOOK

Main description:

Antibiotics are powerful drugs that prevent many deaths each year. Modern medicine relies on them as a safety net. They are a precious global resource that must be managed on a sustainable ecological basis. Many stakeholders believe that an antibiotic crisis is fast approaching or may already be upon us. Owing to the long lead times for antibiotic research and development (R&D), society must act a decade before the need becomes immediately urgent. A central proposition in this report is that it is desirable to develop new business models where the return for investment in R&D on antibiotics is not dependent on the volume of sales, an approach generally known as "delinkage." There is a need to incentivize investment in R&D without also incentivizing sales volumes, which may lead to the over-marketing of antibiotics, the acceleration of the development of resistance, and the undermining of stewardship and conservation measures necessary to limit the growth of resistance.
The report therefore considers the ways in which delinked models could be implemented and the myriad of different challenges involved in moving toward new business models that require global reach to address what is a global problem.


PRODUCT DETAILS

ISBN-13: 9781784130572
Publisher: Royal Institute of International Affairs
Publication date: November, 2015
Pages: 37
Weight: 525g
Availability: Not available (reason unspecified)
Subcategories: General Practice, Pharmacology, Public Health

CUSTOMER REVIEWS

Average Rating